Company page

Crinetics Pharmaceuticals, Inc.

Crinetics Pharmaceuticals, Inc. (Ticker: CRNX) is a public company based in the United States with a market capitalization of approximately $3.78 billion. The company focuses on developing innovative therapies for endocrine diseases and disorders. Crinetics is dedicated to advancing its pipeline of drug candidates to address unmet medical needs in this field.